Alnylam Pharmaceuticals Inc logo

Alnylam Pharmaceuticals Inc

STU:DUL (USA)   Ordinary Shares
€ 273.50 (-0.55%) Oct 18
At Loss
Market Cap:
€ 35.08B ($ 38.15B)
Enterprise V:
€ 33.86B ($ 36.83B)
Volume:
-
Avg Vol (2M):
204.00
Trade In:

Alnylam Pharmaceuticals Inc Valuation Measures